Second-generation immunomodulatory drugs in leptomeningeal myeloma.

Autor: Bohn JP; a Department of Internal Medicine V , Medical University of Innsbruck , Innsbruck , Austria., Willenbacher W; a Department of Internal Medicine V , Medical University of Innsbruck , Innsbruck , Austria.; b Oncotyrol , Center for Personalized Cancer Medicine , Innsbruck , Austria., Peschel I; c Central Institute for Medical and Chemical Laboratory Diagnostics , Medical University Innsbruck , Innsbruck , Austria., Oberacher H; d Institute of Legal Medicine and Core Facility Metabolomics , Medical University of Innsbruck , Innsbruck , Austria., Steurer M; a Department of Internal Medicine V , Medical University of Innsbruck , Innsbruck , Austria.
Jazyk: angličtina
Zdroj: Leukemia & lymphoma [Leuk Lymphoma] 2019 Feb; Vol. 60 (2), pp. 550-552. Date of Electronic Publication: 2018 Jul 22.
DOI: 10.1080/10428194.2018.1492125
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje